Filing Details
- Accession Number:
- 0000950170-25-033845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 17:19:35
- Reporting Period:
- 2025-03-05
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 17:19:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355537 | Hristos Mihael Polymeropoulos | 2200 Pennsylvania Avenue Nw Suite 300E Washington DC 20037 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-05 | 5,000 | $5.01 | 2,280,731 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-03-05 | 5,000 | $5.03 | 2,285,731 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |